 Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores
Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs
ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores
Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores
Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores ACC Ltd consolidated Q2 FY2026 PAT zooms to Rs. 1119.23 crores
ACC Ltd consolidated Q2 FY2026 PAT zooms to Rs. 1119.23 crores 
              The Initial Public Offering (IPO) of Edelweiss Capital Ltd has received overwhelming response from investors with the issue receiving 103.79 times subscription till 4 PM on November 20, 2007.
The issue opened for subscription on November 15, 2007 and closes for subscription today - November 20, 2007.
The issue has received total bids for 870392536 equity shares against the offer of 8386147 equity shares. The issue has received bids for 23250424 equity shares at cut-off price.
The company is issuing 8386147 Equity Shares of Rs 5 each for cash at a price band of Rs 725 to Rs 825 per share through 100% book building process.
Citigroup Global Markets India Private Limited, Kotak Mahindra Capital Company Limited and Lehman Brothers Securities Private Limited are the Book Running Lead Managers to the issue.